Sight Sciences, Inc. (SGHT) stock
SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.49−0.10 (-0.94%)
Close on Nov 17, 2026Market cap $577.87MP/E –Yield –
Sight Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Sight Sciences's enterprise value was $568.66M on Nov 11, 2026, against $386.38M a year earlier. Over the last 5 years it ranged from -$43.80M to $599.03M, with a median of $222.07M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $568.66M | +56.3% |
| 2025 | Dec 31, 2025 | $363.82M | +267.4% |
| 2024 | Dec 31, 2024 | $99.04M | -28.5% |
| 2023 | Dec 29, 2023 | $138.48M | -67.1% |
| 2022 | Dec 30, 2022 | $420.44M | -29.0% |
| 2021 | Dec 31, 2021 | $591.93M | – |
See a number that looks wrong?